drugset / Trial / NCT00710424

A Study of Sativex® for Pain Relief Due to Diabetic Neuropathy

NCT00710424

Phase 3 Completed 297 enrolled Jazz Pharmaceuticals
RandomizedParallel-groupQuadruple-blindSupportive care

Summary

The purpose of this study is to evaluate the efficacy of Sativex® compared with placebo in relieving pain due to Diabetic Neuropathy.

Timeline

Start
2005-07
Primary completion
2006-06
Completion
2006-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Nabiximols Other / unclassified

Indications